Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2845429 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-PR Domain Containing 14 (PRDM14) (AA 1-30), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 1-30, N-Term
- Antibody clone number
- RB1405
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Human primordial germ cell commitment in vitro associates with a unique PRDM14 expression profile.
PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells.
Gene amplification and overexpression of PRDM14 in breast cancers.
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
The yin-yang of PR-domain family genes in tumorigenesis.
Sugawa F, Araúzo-Bravo MJ, Yoon J, Kim KP, Aramaki S, Wu G, Stehling M, Psathaki OE, Hübner K, Schöler HR
The EMBO journal 2015 Apr 15;34(8):1009-24
The EMBO journal 2015 Apr 15;34(8):1009-24
PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells.
Tsuneyoshi N, Sumi T, Onda H, Nojima H, Nakatsuji N, Suemori H
Biochemical and biophysical research communications 2008 Mar 21;367(4):899-905
Biochemical and biophysical research communications 2008 Mar 21;367(4):899-905
Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N, Toyota M, Suzuki H, Honma T, Fujikane T, Ohmura T, Nishidate T, Ohe-Toyota M, Maruyama R, Sonoda T, Sasaki Y, Urano T, Imai K, Hirata K, Tokino T
Cancer research 2007 Oct 15;67(20):9649-57
Cancer research 2007 Oct 15;67(20):9649-57
PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y, Toyota M, Kondo Y, Suzuki H, Imai T, Ohe-Toyota M, Maruyama R, Nojima M, Sasaki Y, Sekido Y, Hiratsuka H, Shinomura Y, Imai K, Itoh F, Tokino T
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Aug 15;13(16):4786-94
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Aug 15;13(16):4786-94
The yin-yang of PR-domain family genes in tumorigenesis.
Jiang GL, Huang S
Histology and histopathology 2000 Jan;15(1):109-17
Histology and histopathology 2000 Jan;15(1):109-17
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC